You have read all your free articles, to continue reading subscribe to read the rest of this content.
Swedish Elypta announced last week that it is one of the winners in the EU program Horizon 2020 SME instrument phase 2 and has been awarded 2.35 million EUR. The grant will fund a multicenter trial for diagnoses of renal cell carcinoma (RCC), aimed at validating the company's metabolism-based liqAlready…
Orion Corporation and CuraTeQ Biologics have expanded their biosimilar distribution agreement to the Baltic countries. The original marketing and distribution agreement signed in 2020 covered the Nordics, Austria, Hungary and Slovenia. Under the agreement, Orion will have the right to sell and maAlready a subscriber Login You have read all…
Oasmia Pharmaceutical is launching its product, Apealea 60 mg, an ovarian cancer treatment drug, in Sweden, Denmark and Finland. The first batch of the drug has been shipped to distributors in these countries, states the company. Transition towards becoming a fully integrated pharmaceutical compAlready a subscriber Login You have read…
Moberg Pharma announces that the company has decided to issue a five-year senior unsecured bond loan in the amount of SEK 300 million with maturity on January 29th, 2021. The bond loan will give a floating rate coupon of Stibor 3m + 6.00% and have a total framework amount of SEK…
